U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06865482) titled 'Clinical Course Of Disease In Participants With FA-CM' on Feb. 18.
Brief Summary: Characteristics and clinical course of disease In participants with cardiomyopathy associated with Friedreich Ataxia (CLARITY-FA)
Study Start Date: April, 2025
Study Type: OBSERVATIONAL
Condition:
Friedreich Ataxia
Cardiomyopathy
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Lexeo Therapeutics
Published by HT Digital Content Services with permission from Health Daily Digest....